Chemoinformaics analysis of octadecyl 2-(2-octadecoxy-2-oxoethyl)sulfanylacetate
| Molecular Weight | 655.127 | nRot | 38 |
| Heavy Atom Molecular Weight | 576.503 | nRig | 2 |
| Exact Molecular Weight | 654.562 | nRing | 0 |
| Solubility: LogS | -8.106 | nHRing | 0 |
| Solubility: LogP | 14.638 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 123 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 78 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 40 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 124.918 |
| nHD | 0 | BPOL | 85.9181 |
| QED | 0.049 |
| Synth | 2.25 |
| Natural Product Likeliness | -0.135 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.039 |
| HIA | 0.004 |
| CACO-2 | -5.521 |
| MDCK | 0.00000421 |
| BBB | 0.001 |
| PPB | 1.0278 |
| VDSS | 3.961 |
| FU | 0.00638834 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.102 |
| CYP2c19-inh | 0.105 |
| CYP2c19-sub | 0.036 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.953 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.004 |
| CYP3a4-inh | 0.157 |
| CYP3a4-sub | 0.012 |
| CL | 5.44 |
| T12 | 0.029 |
| hERG | 0.899 |
| Ames | 0.005 |
| ROA | 0.004 |
| SkinSen | 0.992 |
| Carcinogencity | 0.027 |
| EI | 0.924 |
| Respiratory | 0.552 |
| NR-Aromatase | 0.057 |
| Antiviral | No |
| Prediction | 0.605174 |